Vytrus Biotech, S.A. (BME:VYT)
13.15
-0.05 (-0.38%)
Last updated: Nov 13, 2026, 1:21 PM CET
Vytrus Biotech Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10 | 8.37 | 5.04 | 3.74 | 3.68 | 2.8 | |
Revenue Growth | 44.45% | 65.95% | 35.00% | 1.48% | 31.31% | 64.49% |
Cost of Revenue | 0.89 | 0.86 | 0.59 | 0.35 | 0.35 | 0.26 |
Gross Profit | 9.1 | 7.51 | 4.45 | 3.38 | 3.33 | 2.54 |
Selling, General & Admin | 5.27 | 4.83 | 3.76 | 3.29 | 2.86 | 2.29 |
Other Operating Expenses | -1.72 | -1.46 | -1.12 | -1.03 | -0.83 | -0.73 |
Operating Expenses | 4.57 | 4.35 | 3.47 | 2.98 | 2.72 | 2.13 |
Operating Income | 4.53 | 3.16 | 0.98 | 0.4 | 0.61 | 0.41 |
Interest Expense | -0.08 | -0.08 | -0.12 | -0.15 | -0.2 | -0.12 |
Interest & Investment Income | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 | - |
Currency Exchange Gain (Loss) | -0 | -0 | -0 | -0.01 | -0 | -0 |
Other Non Operating Income (Expenses) | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 |
EBT Excluding Unusual Items | 4.51 | 3.13 | 0.91 | 0.29 | 0.44 | 0.31 |
Asset Writedown | - | - | - | - | - | -0 |
Other Unusual Items | -0 | -0 | -0.01 | 0.02 | 0.01 | 0 |
Pretax Income | 4.51 | 3.13 | 0.9 | 0.31 | 0.45 | 0.31 |
Income Tax Expense | 0.48 | 0.23 | -0.12 | -0.24 | -0.15 | -0.14 |
Net Income | 4.03 | 2.9 | 1.02 | 0.54 | 0.61 | 0.45 |
Net Income to Common | 4.03 | 2.9 | 1.02 | 0.54 | 0.61 | 0.45 |
Net Income Growth | 106.58% | 183.70% | 87.36% | -9.96% | 34.49% | 107.48% |
Shares Outstanding (Basic) | 8 | 8 | 8 | 7 | - | 7 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 7 | - | 7 |
Shares Change | - | -0.10% | 11.71% | - | - | 0.43% |
EPS (Basic) | 0.54 | 0.39 | 0.14 | 0.08 | - | 0.06 |
EPS (Diluted) | 0.54 | 0.39 | 0.14 | 0.08 | - | 0.06 |
EPS Growth | - | 183.99% | 67.72% | - | - | 106.59% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 2.98 | 2.89 | 1.74 | 0.76 | 0.61 | 0.23 |
Free Cash Flow Per Share | 0.40 | 0.38 | 0.23 | 0.11 | - | 0.03 |
Gross Margin | 91.06% | 89.69% | 88.27% | 90.51% | 90.44% | 90.73% |
Operating Margin | 45.35% | 37.70% | 19.52% | 10.82% | 16.48% | 14.60% |
Profit Margin | 40.34% | 34.60% | 20.24% | 14.58% | 16.44% | 16.05% |
Free Cash Flow Margin | 29.80% | 34.48% | 34.55% | 20.41% | 16.45% | 8.11% |
EBITDA | 4.82 | 3.39 | 1.18 | 0.6 | 0.75 | 0.99 |
EBITDA Margin | 48.17% | 40.52% | 23.33% | 15.94% | 20.47% | 35.16% |
D&A For EBITDA | 0.28 | 0.24 | 0.19 | 0.19 | 0.15 | 0.58 |
EBIT | 4.53 | 3.16 | 0.98 | 0.4 | 0.61 | 0.41 |
EBIT Margin | 45.35% | 37.70% | 19.52% | 10.82% | 16.48% | 14.60% |
Effective Tax Rate | 10.57% | 7.33% | - | - | - | - |